Malignant distal biliary stricture due to bile duct cancer, gall bladder cancer, cystic duct cancer, ampullary cancer and lymph node metastasis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with distal malignant biliary obstruction 2. Patients who underwent transpapillary metalic stent placement by means of ERCP 3. Patients who are 20 years of age or older
Exclusion criteria
Exclusion criteria: 1. Former history of endoscopic sphinterotomy before metalic stent placement 2. Patients with pancreatic cancer 3. Patients that the physician in charge consider not suitable for inclusion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of post-ERCP pancreatitis | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Incidence of cholangitis, bleeding and perforation after ERCP 2)Serum amylase level before and after ERCP 3)Incidence of Stent dysfunction and Patency period of stent | — |
Countries
Japan
Contacts
Hokkaido University Hospital Department of Gastroenterology and Hepatology